Notice2022-03053
Center for Scientific Review; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 14, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 30 (Monday, February 14, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 30 (Monday, February 14, 2022)]
[Notices]
[Page 8268]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-03053]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Respiratory Sciences.
Date: March 10, 2022.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Xiang-Ning Li, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112, MSC 7854, Bethesda, MD
20892, 301-435-1744, <a href="/cdn-cgi/l/email-protection#8ce0e5f4e5ede2ebcceffffea2e2e5e4a2ebe3fa"><span class="__cf_email__" data-cfemail="80ece9f8e9e1eee7c0e3f3f2aeeee9e8aee7eff6">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-20-117: Maximizing Investigators Research Award (MIRA)
for Early Stage Investigators (R35--Clinical Trial Optional).
Date: March 14-15, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6107 Rockledge Drive, Bethesda, MD
20892, (301) 402-8559, <a href="/cdn-cgi/l/email-protection#b2d8dbdfddd99cd9dbdff2dcdbda9cd5ddc4"><span class="__cf_email__" data-cfemail="d7bdbebab8bcf9bcbeba97b9bebff9b0b8a1">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Health Services Organization, Delivery, Quality and
Effectiveness.
Date: March 15-16, 2022.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Catherine Hadeler Maulsby, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 435-1266,
<a href="/cdn-cgi/l/email-protection#3f525e4a534c5d465c577f5c4c4d1151565711585049"><span class="__cf_email__" data-cfemail="d3beb2a6bfa0b1aab0bb93b0a0a1fdbdbabbfdb4bca5">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Immune Responses and Vaccines to Microbial
Infections.
Date: March 16-17, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barna Dey, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3184, Bethesda, MD 20892, 301-451-2796,
<a href="/cdn-cgi/l/email-protection#2143454458614c40484d0f4f48490f464e57"><span class="__cf_email__" data-cfemail="6f0d0b0a162f020e06034101060741080019">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Medical Imaging.
Date: March 17-18, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Krystyna H. Szymczyk, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-4198,
<a href="/cdn-cgi/l/email-protection#592a2320343a23203232193a2a2b77373031773e362f"><span class="__cf_email__" data-cfemail="37444d4e5a544d4e5c5c7754444519595e5f19505841">[email protected]</span></a>.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-20-117: Maximizing Investigators' Research Award (MIRA)
for Early Stage Investigators (R35--Clinical Trial Optional).
Date: March 21-22, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas Y. Cho, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge Drive, Room 710B,
Bethesda, MD 20892, 301-402-4179, <a href="/cdn-cgi/l/email-protection#ee9a8681838f9dc08d8681ae808786c0898198"><span class="__cf_email__" data-cfemail="ea9e8285878b99c4898285aa848382c48d859c">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 8, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-03053 Filed 2-11-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 14, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.